Battaglia, Y.; Bulighin, F.; Zerbinati, L.; Vitturi, N.; Marchi, G.; Carraro, G.
Dapaglifozin on Albuminuria in Chronic Kidney Disease Patients with FabrY Disease: The DEFY Study Design and Protocol. J. Clin. Med. 2023, 12, 3689.
https://doi.org/10.3390/jcm12113689
AMA Style
Battaglia Y, Bulighin F, Zerbinati L, Vitturi N, Marchi G, Carraro G.
Dapaglifozin on Albuminuria in Chronic Kidney Disease Patients with FabrY Disease: The DEFY Study Design and Protocol. Journal of Clinical Medicine. 2023; 12(11):3689.
https://doi.org/10.3390/jcm12113689
Chicago/Turabian Style
Battaglia, Yuri, Francesca Bulighin, Luigi Zerbinati, Nicola Vitturi, Giacomo Marchi, and Gianni Carraro.
2023. "Dapaglifozin on Albuminuria in Chronic Kidney Disease Patients with FabrY Disease: The DEFY Study Design and Protocol" Journal of Clinical Medicine 12, no. 11: 3689.
https://doi.org/10.3390/jcm12113689
APA Style
Battaglia, Y., Bulighin, F., Zerbinati, L., Vitturi, N., Marchi, G., & Carraro, G.
(2023). Dapaglifozin on Albuminuria in Chronic Kidney Disease Patients with FabrY Disease: The DEFY Study Design and Protocol. Journal of Clinical Medicine, 12(11), 3689.
https://doi.org/10.3390/jcm12113689
